MSF urges EU to rid market of ‘avoidable suffering’ from SPCs

Médecins Sans Frontières (MSF) has warned that the European Commission’s commitment to the supplementary protection certificate (SPC) system risks undermining its promise to improve drug accessibility.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Europe

UPC appeals court confirms ‘all-or-nothing’ rule for unitary patents

12 February 2026 The court has denied a German non-practising entity’s bid to secure unitary protection for a patent that it has asserted against Intel.

Europe

Reaction: Emotional Perception decision is ‘good for UK PLC’

12 February 2026 UK and European patent attorneys share their initial views after the UK Supreme Court delivered its landmark judgment, which “brings some much‑needed clarity and consistency” to the patentability of AI-related innovations—including those in the medtech industry.

Europe

UK ruling ‘future-proofs’ patentability for AI and computer tech

12 February 2026 The patent community rejoices after the UK Supreme Court's Emotional Perception decision aligns the UK with Europe, paving the way for computer tech companies to protect inventions—including those in the medtech industry.

More features

UPC appeals court confirms ‘all-or-nothing’ rule for unitary patents

Honigman bags second Kirkland litigator this year for IP team

Reaction: Emotional Perception decision is ‘good for UK PLC’

UK ruling ‘future-proofs’ patentability for AI and computer tech

The curtain closes on three major drug disputes

Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’

Novartis takes aim at Tafinlar generic in latest suit

Semaglutide patent battle heats up with new blow for Novo in India

MSF urges EU to rid market of ‘avoidable suffering’ from SPCs

More on this story

Editor's picks

Editor's picks

More features